Genomic variations in the 2'-5' oligoadenylate synthetase 1 (OAS1) gene in zebu cattle and its crossbreds of Indian origin

RANI ALEX; K P RAMESHA; UMESH SINGH; SUSHIL KUMAR; RAFEEQUE R ALYETHODI; RAJIB DEB; SHEETAL SHARMA; GYANENDRA S SENGAR; ASHISH ASHISH; B PRAKASH

doi:10.56093/ijans.v87i11.75889

Authors

RANI ALEX ICAR-Central Institute for Research on Cattle, Meerut Cantt, Uttar Pradesh 250 001 India
K P RAMESHA ICAR-Central Institute for Research on Cattle, Meerut Cantt, Uttar Pradesh 250 001 India
UMESH SINGH ICAR-Central Institute for Research on Cattle, Meerut Cantt, Uttar Pradesh 250 001 India
SUSHIL KUMAR ICAR-Central Institute for Research on Cattle, Meerut Cantt, Uttar Pradesh 250 001 India
RAFEEQUE R ALYETHODI ICAR-Central Institute for Research on Cattle, Meerut Cantt, Uttar Pradesh 250 001 India
RAJIB DEB ICAR-Central Institute for Research on Cattle, Meerut Cantt, Uttar Pradesh 250 001 India
SHEETAL SHARMA
GYANENDRA S SENGAR ICAR-Central Institute for Research on Cattle, Meerut Cantt, Uttar Pradesh 250 001 India
ASHISH ASHISH ICAR-Central Institute for Research on Cattle, Meerut Cantt, Uttar Pradesh 250 001 India
B PRAKASH ICAR-Central Institute for Research on Cattle, Meerut Cantt, Uttar Pradesh 250 001 India

https://doi.org/10.56093/ijans.v87i11.75889

Keywords:

Cattle, Genomic variations, OAS1 gene, Polymorphisms, Zebu cattle

Abstract

In the antiviral host defense mechanisms, the role of mammalian OAS/RNASEL pathway is very significant. These enzymes are interferon-inducible and activated by binding to double-stranded RNA (dsRNA) which are present in virus infected cells. The OAS proteins functions through its receptor, the 2-5Adependent ribonuclease (RNaseL) and activated OAS-RNaseL system degrades viral and cellular RNA and subsequently inhibits protein synthesis. Polymorphisms in the human and equine OAS gene cluster have been previously utilized for casecontrol analysis of virus-induced disease. But no polymorphisms have yet been identified in the bovine OAS1 genes for use in similar case-control studies. The promoter and coding regions of the OAS1 gene was amplified and screened for polymorphisms by PCR-SSCP and sequencing in Sahiwal and Frieswal animals. Two SNPs have been identified in the promoter region of OAS1 gene, which have predicted to create/delete sites for transcription factors. Specific amplification of the exonic regions of the OAS1 gene have identified 26 SNPs and one dinucleotide repeats, among them 14 are mis-sense variants. These polymorphisms are the first to be reported in OAS1 gene and will facilitate future case-control studies of cattle susceptibility to infectious diseases.

Downloads

Download data is not yet available.

Author Biography

SHEETAL SHARMA

Senior Research Fellow, ICAR-Central Institute for Research on Cattle, Meerut Cantt, Uttar Pradesh 250 001 India

References

Almeida G M D, de Oliveira D B, Botelho L M, Silva L K D, Guedes A C M and Santos F P S T. 2014. Differential up- regulation of human 2' 5' OAS genes on systemic sclerosis: detection of increased basal levels of OASL and OAS2 genes through a qPCR based assay. Autoimmunity 47: 119–26. DOI: https://doi.org/10.3109/08916934.2013.866102

Baglioni C. 1979. Interferon-induced enzymatic activities and their role in the antriviral state. Cell 17(2): 255–64. DOI: https://doi.org/10.1016/0092-8674(79)90151-X

Clemens M J and Williams B R. 1978. Inhibition of cell-free protein synthesis by pppA2p5A2p5A: a novel oligonucleotide synthesized by interferon-treated L cell extracts. Cell 13: 565– 72. DOI: https://doi.org/10.1016/0092-8674(78)90329-X

Croze E. 2010. Differential gene expression and translational approaches to identify biomarkers of interferon beta activity in multiple sclerosis. Journal of Interferon and Cytokine Research 30: 743–49. DOI: https://doi.org/10.1089/jir.2010.0022

Der S D, Zhou A, Williams B R and Silverman R H. 1998. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proceedings of the National Academy of Sciences USA 95: 15623–28. DOI: https://doi.org/10.1073/pnas.95.26.15623

Domingo-Gil E and Esteban M. 2006. Role of mitochondria in apoptosis induced by the 2–5A system and mechanisms involved. Apoptosis 11(5):725–38. DOI: https://doi.org/10.1007/s10495-006-5541-0

Dong B and Silverman R H. 1995. 2–5A-dependent RNase molecules dimerize during activation by 2–5A. Journal of Biological Chemistry 270(8): 4133–37. DOI: https://doi.org/10.1074/jbc.270.8.4133

Fedetz M, Matesanz F, Caro-Maldonado A, Fernandez O, Tamayo J A and Guerrero M. 2006. OAS1 gene haplotype confers susceptibility to multiple sclerosis. Tissue Antigens 68(5): 446– 49. DOI: https://doi.org/10.1111/j.1399-0039.2006.00694.x

Field L L, Bonnevie-Nielsen V, Pociot F, Lu S, Nielsen T B and Beck-Nielsen H. 2005. OAS1 splice site polymorphism controlling antiviral enzyme activity influences susceptibility to type 1 diabetes. Diabetes 54(5): 1588–91. DOI: https://doi.org/10.2337/diabetes.54.5.1588

Hamano E, Hijikata M, Itoyama S, Quy T, Phi N C and Long H T. 2005. Polymorphisms of interferon-inducible genes OAS- 1 and MxA associated with SARS in the Vietnamese population. Biochemical and Biophysical Research Communications 329(4): 1234–39. DOI: https://doi.org/10.1016/j.bbrc.2005.02.101

Hertzog P J, Emery P, Cheetham B F, Mackay I R and Linnane A W. 1988. Interferons in rheumatoid arthritis: alterations in production and response related to disease activity. Clinical Immunology and Immunopathology 48: 192–201. DOI: https://doi.org/10.1016/0090-1229(88)90083-9

Johnson G A, Stewart M D, Gray C A, Choi Y, Burghardt R C, Yu-Lee L Y, Bazer F W and Spencer T E. 2001. Effects of the estrous cycle, pregnancy, and interferon tau on 2,5-oligoadenylate synthetase expression in the ovine uterus. Biology of Reproduction 64: 1392–99. DOI: https://doi.org/10.1095/biolreprod64.5.1392

Justesen J, Hartmann R and Kjeldgaard N O. 2000. Gene structure and function of the 2–5-oligoadenylate synthetase family. Cellular and Molecular Life Sciences 57: 1593–1612. DOI: https://doi.org/10.1007/PL00000644

Kakuta S, Shibata S and Iwakura Y. 2002. Genomic structure of the mouse 22,52 -oligoadenylate synthetase gene family. Journal of Interferon and Cytokine Research 22: 981– 93. DOI: https://doi.org/10.1089/10799900260286696

Knapp S, Yee L J, Frodsham A J, Hennig B J, Hellier S and Zhang L. 2003. Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR. Genes and Immunity 4: 411–19. DOI: https://doi.org/10.1038/sj.gene.6363984

Kristiansen H, Scherer C A, McVean M, Iadonato S P, Vends S and Thavachelvam K. 2010. Extracellular 2’-5’ oligoadenylate synthetase stimulates RNase L-independent antiviral activity: a novel mechanism of virus-induced innate immunity. Journal of Virology 84(22): 11898–904. DOI: https://doi.org/10.1128/JVI.01003-10

Li C Z, Kato N, Chang J H, Muroyama R, Shao R X and Dharel N. 2009. Polymorphism of OAS-1 determines liver fibrosis progression in hepatitis C by reduced ability to inhibit viral replication. Liver International 29(9): 1413–21. DOI: https://doi.org/10.1111/j.1478-3231.2009.02061.x

Malathi K, Paranjape J M, Bulanova E, Shim M, Guenther- Johnson J M and Faber P W. 2005. A transcriptional signaling pathway in the IFN system mediated by 2’-5’-oligoadenylate activation of RNase L. Proceedings of the National Academy of Sciences USA 102(41): 14533–38. DOI: https://doi.org/10.1073/pnas.0507551102

Mandal S, Abebe F and Chaudhary J. 2011. 2’-5’ oligoadenylate synthetase 1 polymorphism is associated with prostate cancer. Cancer 117(24): 5509–18. DOI: https://doi.org/10.1002/cncr.26219

Mullan P B, Hosey A M, Buckley N E, Quinn J E, Kennedy R D and Johnston P G. 2005. The 2,5 oligoadenylate synthetase/ RNaseL pathway is a novel effector of BRCA1- and interferon- gamma-mediated apoptosis. Oncogene 24(35): 5492–501. DOI: https://doi.org/10.1038/sj.onc.1208698

Nilsen T W, Maroney P A and Baglioni C. 1981. Double-stranded RNA causes synthesis of 2’,5’-oligo(A) and degradation of messenger RNA in interferon-treated cells. Journal of Biological Chemistry 256(15): 7806–11. DOI: https://doi.org/10.1016/S0021-9258(18)43350-9

Perelygin A A, Lear T L, Zharkikh A A and Brinton M A. 2005. Structure of equine 22–52 oligoadenylate synthetase (OAS) gene family and FISH mapping of OAS genes to ECA8p15- p14 and BTA17q24–25. Cytogenetic and Genome Research 111: 51–56. DOI: https://doi.org/10.1159/000085670

Perelygin A A, Scherbik S V, Zhulin I B, Stockman B M, Li Y and Brinton M A. 2002. Positional cloning of the murine flavivirus resistance gene. Proceedings of the National Academy of Sciences USA 99: 9322–27. DOI: https://doi.org/10.1073/pnas.142287799

Perelygin A A, Zharkikh A A, Scherbik S V and Brinton M A. 2006. The mammalian 22–52 oligoadenylate synthetase gene family: evidence for concerted evolution of paralogous OAS1 genes in Rodentia and Artiodactyla. Journal of Molecular Evolution 63: 562–76. DOI: https://doi.org/10.1007/s00239-006-0073-3

Preble O T, Rothko K, Klippel J H, Friedman R M and Johnston M I. 1983. Interferon induced 2'-5' adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon. Journal of Experimental Medicine 157: 2140–46. DOI: https://doi.org/10.1084/jem.157.6.2140

Quandt K, Frech K, Karas H, Wingender E and Werner T. 1995. Matlnd and Matlnspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Research 23: 4878–84. DOI: https://doi.org/10.1093/nar/23.23.4878

Rios J J, Fleming J G W, Bryant U K, Carter C N, Huber J C and Long M T. 2010. OAS1 polymorphisms are associated with susceptibility to West Nile encephalitis in horses. PLoS ONE 5: e10537. DOI: https://doi.org/10.1371/journal.pone.0010537

Rios J J, Perelygin A A, Long M T, Lear T L and Zharkikh A A. 2007. Characterization of the equine 22–52 oligoadenylate synthetase 1 (OAS1) and ribonuclease L (RNASEL) innate immunity genes. BMC Genomics 8: 313. DOI: https://doi.org/10.1186/1471-2164-8-313

Shastry B S. 2009. SNPs: impact on gene function and phenotype. Methods in Molecular Biology 578: 3–22. DOI: https://doi.org/10.1007/978-1-60327-411-1_1

Stark G R, Kerr I M, Williams B R, Silverman R H and Schreiber R D. 1998. How cells respond to interferons. Annual Review of Biochemistry 67: 227–64. DOI: https://doi.org/10.1146/annurev.biochem.67.1.227

Yaffe A, Schwarz Y, Hacohen D, Kinar Y, Nir U and Salzberg S. 1996. Inhibition of 2–5A synthetase expression by antisense RNA interferes with interferon-mediated antiviral and antiproliferative effects and induces anchorage- independent cell growth. Cell Growth and Differentiation 7(8): 969–78.

Yakub I, Lillibridge K M, Moran A, Gonzalez O Y, Belmont J and Gibbs R A. 2005. Single nucleotide polymorphisms in genes for 2’-5’-oligoadenylate synthetase and RNase L in patients hospitalized with West Nile virus infection. Journal of Infectious Diseases 192(10): 1741–48. DOI: https://doi.org/10.1086/497340

Zhou A, Hassel B A and Silverman R H. 1993. Expression cloning of 2–5A-dependent RNAase: a uniquely regulated mediator of interferon action. Cell 72(5): 753–65. DOI: https://doi.org/10.1016/0092-8674(93)90403-D